DrugPatentWatch Database Preview
« Back to Dashboard
Pemigatinibis the generic ingredient in one branded drug marketed by Incyte Corp and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.
Pemigatinib has seventy-nine patent family members in thirty-four countries.
One supplier is listed for this compound.
Summary for pemigatinib
|Finished Product Suppliers / Packagers:||1|
|Raw Ingredient (Bulk) Api Vendors:||16|
|What excipients (inactive ingredients) are in pemigatinib?||pemigatinib excipients list|
|DailyMed Link:||pemigatinib at DailyMed|
Recent Clinical Trials for pemigatinib
Identify potential brand extensions & 505(b)(2) entrants
|Incyte Corporation||Phase 1|
|Oregon Health and Science University||Phase 1|
|OHSU Knight Cancer Institute||Phase 1|
Pharmacology for pemigatinib
|Drug Class||Kinase Inhibitor |
|Mechanism of Action||Kinase Inhibitors |
Organic Cation Transporter 2 Inhibitors
Multidrug and Toxin Extrusion Transporter 1 Inhibitors
ATC Classes for pemigatinib
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Incyte Corp||PEMAZYRE||pemigatinib||TABLET;ORAL||213736-001||Apr 17, 2020||RX||Yes||No||Get Started Free||Get Started Free||Get Started Free|
|Incyte Corp||PEMAZYRE||pemigatinib||TABLET;ORAL||213736-003||Apr 17, 2020||RX||Yes||Yes||Get Started Free||Get Started Free||Y||Y||Get Started Free|
|Incyte Corp||PEMAZYRE||pemigatinib||TABLET;ORAL||213736-003||Apr 17, 2020||RX||Yes||Yes||Get Started Free||Get Started Free||Get Started Free|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.